CRP is related to higher leptin levels in minority peripubertal females regardless of adiposity levels

Obesity

Volumn 20, Issue 3, 2012, Pages 512-516

  Spruijt Metz, Donna ^a   Adar Emken, B ^a   Spruijt, Mishala R ^b   Richey, Joyce M ^a   Berman, Laura J ^a   Belcher, Britni R ^a   Hsu, Ya Wen ^a   McClain, Arianna D ^a   Lane, Christianne J ^a   Weigensberg, Marc J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WESLEYAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; LEPTIN;

ARTICLE; BODY FAT; BODY MASS; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; PREPUBERTY; RISK FACTOR; SCHOOL CHILD;

ADIPOSITY; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HISPANIC AMERICANS; HUMANS; LEPTIN; LINEAR MODELS; OXIDATIVE STRESS; PUBERTY; RISK FACTORS; UNITED STATES;

EID: 84857689451     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.49     Document Type: Article

References (38)

1. Freeman DJ, Norrie J, Caslake MJ et al.; West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596-1600.
2. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
3. Barzilay JI, Abraham L, Heckbert SR et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384-2389.
4. Järvisalo MJ, Harmoinen A, Hakanen M et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002;22:1323-1328.
5. Blum WF, Englaro P, Hanitsch S et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997;82:2904-2910.
6. Lindquist CH, Gower BA, Goran MI. Role of dietary factors in ethnic differences in early risk of cardiovascular disease and type 2 diabetes. Am J Clin Nutr 2000;71:725-732.
7. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
8. Maffei M, Halaas J, Ravussin E et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-1161.
9. Boden G, Chen X, Kolaczynski JW, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 1997;100:1107-1113.
10. Singhal A, Farooqi IS, Cole TJ et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002;106:1919-1924.
11. Venner AA, Lyon ME, Doyle-Baker PK. Leptin: a potential biomarker for childhood obesity? Clin Biochem 2006;39:1047-1056.
12. Moran A, Steffen LM, Jacobs DR Jr et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 2005;28:1763-1768.
13. Chen K, Li F, Li J et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006;12:425-432.
14. Procopio C, Andreozzi F, Laratta E et al. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. Endocrinology 2009;150:3584-3593.
15. Loffreda S, Yang SQ, Lin HZ et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
16. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000;1-7.
17. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
18. Fields DA, Goran MI, McCrory MA. Body-composition assessment via airdisplacement plethysmography in adults and children: a review. Am J Clin Nutr 2002;75:453-467.
19. Cutfield WS, Bergman RN, Menon RK, Sperling MA. The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab 1990;70:1644-1650.
20. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-122.
21. Pate RR, Ross R, Dowda M, Trost SG, Saland JM. Validation of a 3-Day physical activity recall instrument in female youth. Pediatr Exerc Sci 2003;15:257-265.
22. Pate RR, Stevens J, Webber LS et al. Age-related change in physical activity in adolescent girls. J Adolesc Health 2009;44:275-282.
23. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 2001;50:2444-2450.
24. Carlsson B, Ankarberg C, Rosberg S et al. Serum leptin concentrations in relation to pubertal development. Arch Dis Child 1997;77:396-400.
25. Castell JV, Gómez-Lechón MJ, David M et al. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-1186.
26. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355-365.
27. Wärnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol 2008;19:11-15.
28. Steene-Johannessen J, Kolle E, Reseland JE, Anderssen SA, Andersen LB. Waist circumference is related to low-grade inflammation in youth. Int J Pediatr Obes 2010;5:313-319.
29. Shamsuzzaman AS, Winnicki M, Wolk R et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004;109:2181-2185.
30. Landt M. Leptin binding and binding capacity in serum. Clin Chem 2000;46:379-384.
31. Ma Z, Gingerich RL, Santiago JV et al. Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942-946.
32. Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2007;27:e302-e307.
33. Hukshorn CJ, Lindeman JH, Toet KH et al. Leptin and the proinflammatory state associated with human obesity. J Clin Endocrinol Metab 2004;89:1773-1778.
34. Farooqi IS, O'Rahilly S. Is leptin an important physiological regulator of CRP? Nat Med 2007;13:16-7; author reply 19.
35. Münzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005;8:566-570.
36. Bochud M, Marquant F, Marques-Vidal PM et al. Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab 2009;94:3969-3977.
37. Ridker PM, Pare G, Parker A et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008;82:1185-1192.
38. Apter D. The role of leptin in female adolescence. Ann N Y Acad Sci 2003;997:64-76.